29636922|t|Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy.
29636922|a|Hyperammonemia is a rare adverse effect of 5-fluorouracil (5-FU) therapy, but can be very serious, even fatal. Physicians must be aware that hyperammonemic encephalopathy sometimes develops as an adverse event after 5-FU therapy.
29636922	0	29	Hyperammonemic encephalopathy	Disease	MESH:D001927
29636922	35	42	patient	Species	9606
29636922	53	77	fluorouracil/oxaliplatin	Chemical	-
29636922	92	106	Hyperammonemia	Disease	MESH:D022124
29636922	135	149	5-fluorouracil	Chemical	MESH:D005472
29636922	151	155	5-FU	Chemical	MESH:D005472
29636922	233	262	hyperammonemic encephalopathy	Disease	MESH:D001927
29636922	308	312	5-FU	Chemical	MESH:D005472
29636922	Positive_Correlation	MESH:D005472	MESH:D022124
29636922	Positive_Correlation	MESH:D005472	MESH:D001927

